BioSpace News Archive

Bicycle Therapeutics plc today announced that it has commenced an underwritten public offering of $125,000,000 of American Depositary Shares (“ADSs”), each representing one ordinary share.

CureVac N.V. today announced the strategic decision to focus its COVID-19 vaccine development towards the development of second-generation mRNA vaccine candidates in collaboration with GSK and to withdraw its first-generation COVID-19 vaccine candidate, CVnCoV, from the current approval process with the European Medicines Agency (EMA).

BridgeBio Pharma, Inc. is announcing meaningful progress in its KRAS cancer portfolio, new programs in gene therapy, and advancements in cardiorenal and early-stage Mendelian programs at its second annual R&D Day today.

Integral Molecular, a founding member of Philadelphia’s biotech community, celebrates its 20th anniversary as a leader in antibody discovery and virology.

Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) The extra general meeting was held today on 12 October 2021 and the following resolutions were passed by the meeting.

With this important addition to its Board of Directors, Science 37 further advances its mission to accelerate clinical trials by enabling universal access to patients and providers.

Vor Biopharma, a clinical-stage cell and genome engineering company, announced the appointment of Veit Schmelmer, Ph.D., as Vor’s Senior Vice President of Program and Alliance Management.

Histopathology can be defined as the examination of various diseases that are liked to tissues. Conducted with the help of microscopes, products in the global histopathology testing equipment market examine the characteristics of these diseases.

Endoscopes are mainly defined as slender optical instruments that are used to gain an interior view in the body being examined.

The emergence of sensor technology and continuous advancements in the technology play a pivotal role in the growth of the global market for disposable medical sensors.